Clinical Trial Update: Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer [NA]

View source ↗

Summary

This clinical trial is evaluating whether combining polygenic risk stratification with mpMRI can better identify clinically relevant prostate cancer, and the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Adam S. Kibel, MD | Conditions: Prostate Cancer, Polygenic Risk Score | NA | Status: RECRUITING